Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 16, 2026
Nutra Pharma Revenue
Nutra Pharma had revenue of $57.92K in the quarter ending June 30, 2026, a decrease of -52.58%. This brings the company's revenue in the last twelve months to $258.91K, down -44.15% year-over-year. In the year 2025, Nutra Pharma had annual revenue of $385.31K, down -1.74%. That makes Nutra Pharma the 45,227th largest company in the world by revenue and 6,552nd in the United States.
Revenue (ttm)
258.91K
Revenue Growth
-44.15%
P/S Ratio
2.77
Revenue / Employee
43.15K
Employees
6
Market Cap
715.97K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 385.31K | -6.84K | -1.74% |
| Dec 31, 2024 | 392.15K | -202.73K | -34.08% |
| Dec 31, 2023 | 594.88K | 156.61K | 35.73% |
| Dec 31, 2022 | 438.27K | 340.54K | 348.43% |
| Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioXcel Therapeutics | 742.00K |
| LiveWire Ergogenics | 571.68K |
| Sky Century Investment | 126.22K |
| Full Alliance Group | 82.12K |
| American Green | 48.63K |
| Kaya Holdings | 26.69K |
| Sibannac | 434.00 |